Hamsters Are a Better Model System than Rats for Evaluating the Hypocholesterolemic Efficacy of Potential Probiotic Strains

Scope Rats and hamsters are the most commonly used animal models for evaluating the hypocholesterolemic activity of potential probiotic strains, whereas little or no information has been reported on whether the animal models would affect the experimental conclusions regarding the hypocholesterolemic efficacy of the strains. Methods and results Both high‐cholesterol‐fed rats and hamsters were intragastrically administered viable cells of bile salt hydrolase‐active Lactobacillus acidophilus K16 once daily (1 × 1010 CFU per kg body weight) for 28 d. It was found that the strain did not significantly (p > 0.05) affect the serum and hepatic cholesterol levels in rats, whereas it significantly decreased (p < 0.01 or p < 0.001) the serum total and non‐HDL‐cholesterol as well as hepatic‐free, esterified, and total cholesterol levels in hamsters by 29.6%, 38.8%, 15.8%, 36.2%, and 34.0%, respectively. Conclusion These data suggest that the hypocholesterolemic efficacy of L. acidophilus K16 is substantially different between high‐cholesterol‐fed hamsters and rats and that hamsters are a better model system than rats for evaluating the hypocholesterolemic efficacy of potential probiotic strains due to their similarity to humans in biliary bile acid composition, including types of bile acids and their conjugation form. Both high‐cholesterol‐fed rats and hamsters are intragastrically administered viable cells of Lactobacillus acidophilus K16 for 28 days. Hypocholesterolemic efficacy of the strain is different between the two types of animal models. Hamsters are a better animal model system than rats for evaluating the hypocholesterolemic efficacy of potential probiotic strains due to their similarity to humans in biliary bile acid composition.